New Haven-based biomedical company Precipio Diagnostics has completed a merger with a Nebraska provider of cancer detection services.

Connecticut Innovations invested $750,000 in Precipio in 2013 when it led an overall Series B investment round of $1.8 million.

The company offers services that enable more accurate disease diagnoses.

more